Citations

Clear

174 citation(s) found for "Jentzer, J C".

Evaluating the role of lower extremity elastic bandage in patients with acute decompensated heart failure
Nikravangolsefid, Nasrin , Wei, Li Fang, Zieminski, Joseph J , Jentzer, Jacob C , Kashani, Kianoush B

Mayo Clinic

European Journal of Heart Failure | October 13, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/ejhf/xuag322 | PMID 42874074 Get It

Abstract Background Lower extremity compression therapy has been proposed as an adjunct to mitigate diuretic resistance during acute decompensation of heart failure (ADHF). We evaluated the effect of lower leg compression with elastic bandages on diuretic efficiency in patients with diuretic-resistant ADHF. Methods Historical cohort study enrolling adult cardiac intensive care unit admissions with ADHF who used elastic bandages (EBs) at Mayo Clinic in Minnesota from 2007 to 2017. The diuretic efficiency before and after applying EB was the primary outcome. Results A total of 176 patients with heart failure who received elastic bandages were included. The in-hospital mortality rate, the median hospital length of stay, and 30-day hospital readmission were 9.7%, 11.4 days (interquartile range 7.1–19.0), and 11%, respectively. When EB was applied, the average daily loop diuretic dosage was decreased by a mean difference of 1.19 mg per 40 mg furosemide equivalent [95% confidence interval (CI): 0.22–2.2; P = .016]. The average post-EB diuretic efficiency was 1355 mL (interquartile range 1119–1590) per 40 mg furosemide, which was significantly higher than before EB application, with a mean difference of 340 mL per 40 mg furosemide equivalent (95% CI: −554 to −125; P = .002). A higher diuretic efficiency led to lower diuretic doses. Average daily urine output before and after EB application was not different (2642 pre-EB vs 2792 post-EB mL/day; 95% CI: −455 to 154; P = .33). Conclusion EB use enhances diuretic efficacy during ADHF. Further studies are needed to determine the potential clinical benefits and risks of applying EB compression treatment in ADHF.
Cardiac mechanical efficiency in patients with cardiogenic shock
Berg‐Hansen, Kristoffer , Hørsdal, Oskar Kjærgaard , Nielsen, Roni , Ito, Saki , Borlaug, Barry A. , Jentzer, Jacob C. , Wiggers, Henrik , Nielsen, Roni , Ito, Saki , Borlaug, Barry A , Hillerson, Dustin , Jentzer, Jacob C , Hillerson, Dustin

Mayo Clinic

European Heart Journal: Acute Cardiovascular Care | July 21, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/ehjacc/zuag098 | PMID 42484289 Get It

Abstract Aims Cardiogenic shock (CS) is characterized by impaired left ventricular (LV) mechanical performance and adverse remodelling. We evaluated whether transthoracic echocardiography (TTE)-derived modified cardiac efficiency (mCE), integrating stroke work and residual LV volume, is associated with short- and long-term mortality in CS and whether its prognostic value differs by shock aetiology. Methods and results In this retrospective cohort study, consecutive adults admitted with CS to the cardiac intensive care unit at Mayo Clinic (2007–2018) were included if TTE was performed within 24 h. mCE was calculated as (stroke volume × estimated LV end-systolic pressure) divided by LV end-systolic volume and categorized into quartiles. Primary outcome was in-hospital mortality; secondary outcome was 1-year mortality. Multivariable logistic and Cox models adjusted for illness severity, comorbidity burden, shock aetiology, cardiac arrest, vasoactive therapy, and mechanical circulatory support. Among 667 patients, median mCE was 48 mmHg (IQR 32–74). In-hospital mortality was 28% and increased stepwise across decreasing mCE quartiles. The lowest quartile had a 2.5-fold higher adjusted odds of in-hospital death (OR 2.53; 95%CI: 1.49–4.37; P < 0.001). One-year mortality was 41%; the lowest quartile had a two-fold higher adjusted hazard of death (HR 2.05; 95%CI: 1.45–2.89; P < 0.001). Associations were stronger in acute coronary syndrome-related CS (interaction P = 0.035 for in-hospital; P = 0.015 for 1-year). Within the lowest quartile, reduced systolic pressure further amplified mortality risk. Conclusion Early TTE-derived mCE was independently associated with short- and long-term mortality in CS, particularly in acute coronary syndrome-related CS, and captured the interaction between ventricular remodelling and mechanical performance underlying high-risk phenotypes.
Prognostic impact of ventricular arrhythmia timing in acute coronary syndromes treated with percutaneous coronary intervention: a systematic review and meta-analysis
Pizzi, D, Fazzini, L, Pugliesi, G M, Faizan, M A, Rehman, T, Meshkati, H, Perego, G B, Curti, E, Senni, M, Gori, M, Jentzer, J J, Fazzini, Luca , Pugliesi, Giordano Maria , Rehman, Tooba , Perego, Giovanni Battista , Curti, Emanuele, Senni, Michele , Gori, Mauro

Mayo Clinic

Europace | June 25, 2026 | Volume: 28 | Issue: Supplement_1 | Pages: No page available

10.1093/europace/euag105.1031 Get It

Abstract Background Ventricular arrhythmias (VA) are common complications of acute coronary syndromes (ACS) and can cause cardiac arrest and adverse outcomes. However, the prognostic impact of VA according to their timing in relation to percutaneous coronary intervention (PCI) remains unclear. Purpose To assess the prognostic significance of VA in patients with ACS undergoing PCI according to the timing of occurrence (before, during, or after PCI). Methods We performed a systematic review and meta-analysis of observational studies reporting all-cause mortality with and without VA (sustained VT/VF) in ACS patients undergoing PCI. Pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated using random-effects models for short-term (30 days/in-hospital) and long-term (1 year) mortality. Between-study heterogeneity was assessed using the I² statistic. We conducted subgroup analyses for studies that stratified VA according to timing, defined as VA before PCI (prior to arrival in the catheterization laboratory), VA during PCI (in the catheterization laboratory or immediately after reperfusion), VA after PCI (following completion of PCI). Each timing category was compared to patients who did not develop VA within the same time window (before, during or after PCI). Results Twelve studies comprising 49306 patients were included, of whom 4320 (8.76%) experienced VA. The mean age of the patients ranged from 60 to 70 years, and the follow-up ranged from hospital discharge to 8 years. VA was associated with increased short-term (OR 5.02 [3.91-6.44]) and long-term mortality (OR 3.00 [2.86-3.82]). However, in patients alive at discharge/30 days, subsequent long-term mortality risk did not differ between those with and without VA (OR 1.21 [0.70-2.09]) (Figure 1). The subgroup analyses showed that patients with VA were associated with higher short-term mortality compared to patients without VA within each time window: before (OR 4.32 [3.29-5.66]), during (OR 4.29 [2.08-8.84]), and after PCI (OR 9.29 [3.12-27.63]) (Figure 2). VA after PCI was associated with the highest OR for short-term mortality. Conclusions VA significantly worsens short-term outcomes in ACS patients undergoing PCI. Subgroup analysis shows that VA increases mortality in each timing category, before, during and after PCI, with the poorest prognosis observed for arrhythmias developed after reperfusion, in whom reversible acute ischemia may play a lesser role and underlying arrhythmic substrate may predominate.Figure 1Figure 2
Early Corticosteroid use and Clinical Outcomes in Patients with Mixed and Cardiogenic Shock
Gastanadui, Maria Gabriela , Murphy, Hannah R. , Shahu, Andi, Safiriyu, Israel , Heck, Cory, Hysolli, Maria, Garimella, Sanjana, Ali, Tariq , Jentzer, Jacob C., Gage, Ann, Katz, Jason N. , Miller, P. Elliott, Jentzer, Jacob C. , Jentzer, Jacob C , Miller, P Elliott , Gastanadui, Maria Gabriela , Safiriyu, Israel , Heck, Cory, Callegari, Santiago , Garimella, Sanjana , Gage, Ann , Jacobs, Mark , Miller, P. Elliott

Mayo Clinic

Journal of Intensive Care Medicine | June 1, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/08850666261437767 | PMID 42223374 Get It

Background The pathophysiology of CS is complex and is associated with increased inflammation and impaired vascular tone. Corticosteroids are recommended in septic shock and have been proposed as a potential treatment for other types of shock. Objectives We sought to evaluate the clinical outcomes associated with early corticosteroid use in patients with cardiogenic shock (CS). Methods Using a nationally representative database including over 1000 hospitals, we identified adults ≥18 years of age admitted from 2015–2023 with a diagnosis of CS. Patients with adrenal insufficiency, chronic rheumatologic conditions, COVID-19 infection and acute COPD exacerbation were excluded. Using inverse probability treatment weighting (IPTW), we assessed for the association of receiving early corticosteroids (within the first 2 days of admission) versus no early corticosteroids and in-hospital mortality. Results Of the 167,721 identified patients with CS, the mean (SD) age was 65.5 (±15.2) years and 35.0% were women. A total of 13.2% received any corticosteroid within the first 2 days of admission. The most common corticosteroid was hydrocortisone (73.9%). Mortality for those receiving and not receiving early corticosteroids was 48.8% and 29.6% ( p < 0.001), respectively. After IPTW, early corticosteroid use remained associated with a 3.1% (95% confidence interval [CI]: 2.4% to 3.8%, p < 0.001) higher mortality. Among patients with CS and concomitant sepsis, 27.6% received early corticosteroids, which was similarly associated with a higher mortality (weighted mean 5.8% [95% CI: 4.6% to 7.0%, p < 0.001]). Conclusions Approximately 1 in 7 patients with CS received corticosteroids early during their admission, which was associated with higher in-hospital mortality.
Cardiac mechanical efficiency as a predictor of in-hospital mortality in patients with cardiogenic shock
Horsdal, O K, Berg-Hansen, K, Oh, J, Ito, S, Borlaug, B, Nielsen, B R R, Wiggers, H, Jentzer, J C, Hørsdal, Oskar Kjærgaard , Wiggers, H, Jentzer, Jacob C.

Mayo Clinic

European Heart Journal: Acute Cardiovascular Care | May 13, 2026 | Volume: 15 | Issue: Supplement_1 | Pages: No page available

10.1093/ehjacc/zuag046.173 Get It

Abstract Background Cardiogenic shock (CS) is characterized by critically low cardiac output and impaired myocardial energy transfer to cardiac work. Left-ventricular (LV) cardiac mechanical efficiency (CE), defined as the fraction of total pressure-volume area (PVA) converted to external work (EW), captures how effectively the LV converts energy into stroke work. Because CE integrates load, chamber volumes, and pump performance into a single physiologic construct, it may directly reflect the energy-work mismatch that characterizes CS. The prognostic value of transthoracic echocardiography (TTE)-derived CE for in-hospital outcomes in CS remains uncertain. Purpose To determine whether TTE-derived CE measured within 24 hours of admission predicts in-hospital mortality in patients with CS, and to compare its discriminatory performance with LV ejection fraction (LVEF). Methods Data from CS patients admitted between 2007 and 2018 were analyzed. First LV end-systolic pressure (LVESP=0.9×systolic blood pressure), stroke volume (SV), and LV end-diastolic pressure (LVEDP, estimated using the Nagueh formula) was estimated. CE was then estimated based on EW (EW=(LVESP×SV)−(SV×LVEDP)), potential energy (PE=0.5×LVESP×LV end-systolic volume) and PVA (EW+PE) as CE=EW/PVA×100. We assessed CE and LVEF by TTE performed within 24 hours of admission. Patients were separated into tertiles of CE: high (&gt;47%), moderate (36% &lt; CE ≤47%), and low (CE ≤36%). The primary endpoint was in-hospital mortality. A key secondary endpoint was cardiac intensive care unit (CICU) mortality. Associations were tested with multivariable logistic regression (pre-specified covariates including LVEF). Results A total of 577 patients were included. Median age was 69 (IQR: 59-78) years, 38% were females and 65% had acute coronary syndrome. CICU mortality was 20% and total in-hospital mortality was 29%. Patients with low CE had a lower LVEF compared with patients with moderate or high CE (21% (IQR:19-24%) vs 31% (IQR: 28-33%) and 45% (39-51%) respectively). Median CE was 40.5% (IQR 31.8–51.0%) and was lower for in-hospital deaths (37.1% vs 42.1%, P&lt;0.001). Patients with lower CE exhibited significantly higher CICU (P=0.003) and in-hospital mortality (P&lt;0.001; Figure 1). Patients with CE in the lowest tertile had significantly increased risk of CICU and in-hospital death (Figure 2) compared with moderate or high CE tertiles. In multivariate analysis, every 1% decrease in CE corresponded to an 10% increased risk of CICU death and an 8% increased risk of in-hospital death. When both CE and LVEF were included in the same multivariate model, both were significant predictors of CICU death, while only CE remained a significant predictor of in-hospital death. Conclusion In patients with CS, TTE-derived CE measured within 24 hours of admission predicts early risk of death, underscoring the prognostic importance of LV energy-work coupling as a marker of disease severity beyond LVEF measurement.Figure 1: Figure 2:
Diuretic resistance and associated mortality outcomes among patients in the cardiac intensive care unit
Patel, P, Reddy, Y, Sen, A, Kashani, K, Jentzer, J C, Reddy, Yogesh N.V. , Kashani, Kianoush , Jentzer, Jacob C.

Mayo Clinic

European Heart Journal: Acute Cardiovascular Care | May 13, 2026 | Volume: 15 | Issue: Supplement_1 | Pages: No page available

10.1093/ehjacc/zuag046.169 Get It

Abstract Background Diuretic resistance (DR) is the failure to achieve adequate natriuresis despite high diuretic doses, reflecting a state of low diuretic efficiency (DE). In heart failure (HF) and general intensive care cohorts, low DE and the presence of DR have been associated with adverse outcomes, including increased risk of rehospitalization and mortality (1-3). Quantitative data, however, remains limited in patients admitted to the cardiac intensive care unit (CICU) – a population characterized by cardiac critical illnesses and substantial cardiorenal interactions. Purpose The aim of this study is to investigate and characterize the association between DR and associated mortality outcomes in CICU patients. Methods This retrospective cohort study included adult CICU patients (2007-2018) who received loop diuretics on day 1 of admission. Patients with a stay &lt;1 day or oliguria [&lt;400mL urine output (UOP) total] were excluded. DR was defined as &lt;500mL of UOP per 40mg oral furosemide equivalent (FSE). Acute kidney injury (AKI) was defined per KDIGO guidelines. Primary outcome was all-cause in-hospital mortality (including CICU deaths), and secondary outcome was all-cause 1-year mortality. In-hospital mortality predictors were evaluated using logistic regression and 1-year mortality predictors by Cox proportional-hazards models. 1-year survival was assessed using Kaplan-Meier curves. Multivariable models were adjusted for known confounders. Results 3,229 total patients were included. Median age was 71.2 (61.2, 80.7) years and 41.3% were female. Admission diagnoses included HF exacerbation (79.9%), acute coronary syndrome (34.5%), and respiratory failure (38.9%), among others. 1,098 (34.0%) patients met DR criterion; they had higher severity of illness scores, more comorbidities (including HF, diabetes mellitus, lung disease, and chronic kidney disease, p&lt;0.001), and greater laboratory derangements. On admission, 23.6% patients had AKI, of which 54.3% patients met DR criterion. During hospitalization, 56.0% patients had AKI; those with DR had higher prevalence and severity of AKI (unadjusted OR 3.55 [3.02-4.17], p&lt;0.001). Overall in-hospital mortality was 9.8% (including 5.2% in the CICU). In patients with DR, in-hospital mortality was 17.0% (9.7% in the CICU). Notably, 59.4% of all in-hospital deaths occurred in patients with DR. DR was independently associated with higher in-hospital (adjusted OR 2.00 [1.51-2.64], p&lt;0.001) and 1-year (adjusted HR 1.64 [1.44-1.88], p&lt;0.001) mortality. Patients with DR had higher mortality in each AKI stage (Figure 1), and patients with concomitant DR and AKI had the highest risk of 1-year mortality (Figure 2). Conclusion DR, defined by our easily applicable threshold, emerged as a powerful, independent predictor of adverse outcomes and was associated with substantially higher mortality, demonstrating potential as a valuable risk stratifying tool.
Minimum mean arterial pressure and in-hospital mortality in the cardiac intensive care unit: an admission diagnosis subgroup analysis
Patel, P, Dahiya, G, Hibbert, B, Hillerson, D, Jentzer, J C, Dahiya, Garima , Hibbert, Benjamin , Hillerson, Dustin , Jentzer, Jacob C.

Mayo Clinic

European Heart Journal: Acute Cardiovascular Care | May 13, 2026 | Volume: 15 | Issue: Supplement_1 | Pages: No page available

10.1093/ehjacc/zuag046.168 Get It

Abstract Background Hypotension is a recognized predictor of mortality in the cardiac intensive care unit (CICU) (1-3). Although prior studies link lower mean/averaged mean arterial pressure (MAP) to adverse outcomes, they highlight the need for dedicated research on the minimum MAP (mMAP), as mean data may fail to capture the clinical significance of brief, severe hypotensive episodes. Purpose This study aims to investigate the mortality outcomes associated with the mMAP within the first 24 hours of CICU admission and further stratified according to admission diagnoses. Methods This retrospective cohort study included adult CICU patients with available mMAP data (2007-2018). Patient data were extracted including admission diagnoses, critical care therapies (hemodynamic/ventilatory support, continuous renal replacement therapy), comorbidities, vital signs, lab values, and mortality outcomes. MAP was measured either invasively (arterial catheter) or non-invasively (blood pressure cuff). Primary exposure was mMAP, defined as the lowest recorded MAP in first 24 hours of CICU admission. Primary outcome was in-hospital mortality analyzed using logistic regression, before and after multivariable adjustment. Mortality outcomes were analyzed according to mMAP and stratified by admission diagnoses (not mutually exclusive). Results 11,930 patients were included. Median age was 69.4 (58.1, 79.2) years and 37.7% were female. Admission diagnoses included heart failure (48.7%), acute coronary syndrome (42.7%), shock (14.9%), and cardiac arrest (11.8%). Critical care therapies were used in 58.5%. Median mMAP was 54 (47, 62) mmHg. 1080 (9.1%) patients died during hospitalization, including 672 (5.6%) in the CICU. Median mMAP was lower in patients who died in the CICU (46 vs. 55 mmHg, p&lt;0.001) and during the hospitalization (47 vs. 55 mmHg, p&lt;0.001). In the overall cohort, the lowest mortality was at mMAP of 71-75 mmHg. Patients with lower mMAP had higher mortality across admission diagnosis subgroups (Fig1). The mMAP associated with the nadir mortality was slightly higher for acute coronary syndrome or cardiac arrest patients (66-70 mmHg) than for heart failure or cardiogenic shock patients (61-65 mmHg) (Fig2). Each 5 mmHg increase in mMAP was associated with lower in-hospital mortality in patients with (unadj OR 0.81 [0.79-0.84], AUC 0.64) and without (unadj OR 0.76 [0.71-0.82], AUC 0.67) critical care therapies. Conclusion Our findings re-affirm that hypotension is a significant predictor of mortality, consistent across all admission diagnoses. Notably, the mMAP range associated with the lowest in-hospital mortality was slightly lower for patients with circulatory failure (heart failure or cardiogenic shock) compared to those with acute coronary syndromes or cardiac arrest. This difference may represent an optimal balance between maintaining perfusion and preventing excessive afterload in the setting of circulatory failure, but further investigation is required.1) Mortality Per mMAP & Admission Diag 2) Nadir Mortality Point
The authors reply:
Wang, Jeffrey , Jentzer, Jacob C., Tonna, Joseph E. , Jentzer, Jacob C. , Wang, Jeffrey

Mayo Clinic

Critical Care Medicine | May 5, 2026 | Volume: 54 | Issue: 5 | Pages: 1277-1278

10.1097/ccm.0000000000007052 | PMID 42084933 Get It

Acute Kidney Injury and Outcomes in the Cardiac Intensive Care Unit: Insights from the Critical Care Cardiology Trials Network
Padkins, Mitchell , Papolos, Alexander , Kenigsberg, Benjamin B. , Katz, Jason N., Diepen, Sean van, Steverson, Alexandra K., Rose, Scott W. , Wang, Jeffrey, Park, Jeong‐Gun , Barsness, Gregory W. , Jentzer, Jacob Colin, Diepen, Sean van , Singam, N Sarma V , Padkins, Mitchell R , van Diepen, Sean , Jentzer, Jacob C , Singam, Narayana Sarma V. , Berg, David D. , Katz, Jason N , Bohula, Erin A. , Morrow, David A. , Jentzer, Jacob C.

Mayo Clinic

Journal of Intensive Care Medicine | April 9, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/08850666261440201 | PMID 41954488 Get It

Background Acute kidney injury (AKI) is associated with high morbidity and mortality in critically ill patients. Multicenter analyses describing the epidemiology of AKI in the cardiac intensive care unit (CICU) are scarce. Here, we describe the prevalence, predictors, and outcomes associated with AKI in a contemporary multicenter CICU population. Methods The Critical Care Cardiology Trials Network (CCCTN) is a collaboration of CICUs in North America coordinated by the TIMI Study Group (Boston, MA). We evaluated patient and hospital-level outcomes as a function of creatinine-only Kidney Disease: Improving Global Outcomes (KDIGO) AKI stage within the CCCTN registry. Logistic regression was used to assess associations with in-hospital mortality. Results Among 21 603 admissions, the overall prevalence of AKI was 23.7%, which was composed of KDIGO stage 1: 12.7%, stage 2: 1.7%, and stage 3: 9.2%. A higher prevalence and severity of AKI were seen in patients with baseline kidney disease, hypertension, or diabetes and in admissions with heart failure, cardiogenic shock, and cardiac arrest ( P < .001 for all). There was a stepwise increase in hospital mortality across AKI stages (stage 1: 23%, stage 2: 39%, stage 3: 42%; P < .0001). The increased risk of death associated with progressive AKI stage persisted after multivariate adjustment (adjusted OR: stage 1: 2.1, stage 2: 3.7, stage 3: 3.4). Conclusions AKI occurs in 1 in 4 admissions to the CICU, and a higher AKI stage is incrementally associated with in-hospital mortality, highlighting a need to develop strategies to mitigate AKI and its complications.
Right Ventricular Function and Mortality in Critically Ill Patients With Heart Failure and Cardiogenic Shock
Lipps, Kirsten , Dahiya, Garima , Jokhadar, Maan , Bennett, Courtney , Ternus, Bradley , Crespo-Diaz, Ruben, Jentzer, Jacob C. , Lipps, Kirsten M , Bennett, Courtney E, Hillerson, Dustin , Crespo-Diaz, Ruben J, Jentzer, Jacob C , Hillerson, Dustin , Crespo‐Diaz, Ruben

Mayo Clinic

International Journal of Heart Failure | April 9, 2026 | Volume: 8 | Issue: 2 | Pages: 147

10.36628/ijhf.2026.0004 | PMID 42110710 Get It